0.5200CAD0.00%Mkt Cap: 26.93M $P/E: 26.002d ago
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
CRY
GraniteShares YieldBOOST CRCL ETF—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
—
—
Indicators:|
Key Statistics
Company
Market Cap26.93M $
Enterprise Value24.95M $
Revenue (TTM)13.44M $
Gross Profit10.88M $
Net Income (TTM)939.26K $
Revenue/Share0.1886 USD
Last Price0.5200 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)26.00
P/E (Forward)—
PEG6.53
EV/EBITDA11.82
EV/Revenue1.86
P/S2.00
P/B5.15
EPS (TTM)0.02
EPS (Forward)—
52W Range
0.2900100% of range0.5200
52W High0.5200 CAD
52W Low0.2900 CAD
Profitability
Gross Margin83.28%
Oper. Margin24.99%
EBITDA Margin15.71%
Profit Margin7.19%
ROE16.92%
ROA3.52%
Growth
Revenue Growth11.60%
Earnings Growth166.70%
Cash Flow & Leverage
Operating CF3.62M $
CapEx (TTM)251.27K $
FCF Margin18.30%
FCF Yield9.13%
Net Debt-3.18M $
Net Debt/EBITDA-1.51
Balance Sheet
Debt/Equity0.05
Current Ratio1.16
Quick Ratio0.18
Book Value/Sh0.1010 CAD
Cash/Share0.0660 CAD
Dividends
Fwd Div Rate0.0100 CAD
Trail. Div Rate0.0150 CAD
Div. Yield1.92%
5Y Avg Yield—
Payout Ratio62.50%
Ex-Div DateApr 24, 2026
Pay DateApr 28, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.71.12M
Float44.82M
Insiders36.97%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short3.64K
Short (prev mo.)192
Technical
SMA 500.4340 (+19.8%)
SMA 2000.3907 (+33.1%)
Beta0.51
S&P 52W Chg19.63%
Avg Vol (30d)91.99K
Avg Vol (10d)6.75K
Technical Indicators
RSI (14)73.6
MACD0.0224
MACD Signal0.0186
MACD Hist.+0.0038
BB Upper0.5155 CAD
BB Middle0.4637 CAD
BB Lower0.4120 CAD
BB Width22.34%
ATR (14)0.0115 CAD
Vol Ratio (20d)0.09x